Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy

Table 2 Current clinical trials listed at http://www.clinicaltrials.gov (research August 2010) employing mesenchymal stromal cells from umbilical cord blood, umbilical cord or placenta or case studies applying mesenchymal stromal cells from perinatal sources

UCB-MSCs	Safety and efficacy study of umbilical cord blood-derived mesenchymal stem cells to promote engraftment of unrelated hematopoietic stem cell transplantation
UCB-MSCs	Safety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
UCB-MSCs	Stem cell therapy for type 1 diabetes mellitus
UCB-MSCs	Study to compare the efficacy and safety of cartistem® and microfracture in patients with knee articular cartilage injury or defect
UC-MSCs	A research study looking at specific tissue of the umbilical cord
UC-MSCs	Allogeneic mesenchymal stem cell for Graft-versus-host disease treatment
UC-MSCs/Placenta-MSCs	Safety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
Placenta-MSCs	Safety of intramuscular injection of Allogeneic PLX-PAD cells for the treatment of critical limb ischemia
UCB-MSCs	Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model[103]
UCB-MSCs	A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study[104]